Every pharmaceutical business process, from buying an API to releasing a batch, now faces closer checks than ever before. Regulators expect complete batch records. Buyers expect full traceability. At the same time, margins keep getting thinner. So pharma companies that still run on paper registers, spreadsheets and disconnected software must change. This guide explains what to change first and how eresource Bpro ERP for the pharmaceutical industry helps.
Key takeaways
- Rules are stricter: India’s revised Schedule M now applies to every manufacturer, so paper-based GMP is harder to defend.
- Records must be digital: electronic batch records and lot-wise traceability make audits faster and safer.
- Quality must be built in: QC, deviations and CAPA should sit inside the same system as production.
- Costs must be visible: batch-wise costing also shows which products really make money.
Why pharma companies must change their business processes now
Five pressures are pushing pharma manufacturers to rethink how they work. Together, they make the old way of running a plant risky.
1. Stricter GMP rules
India notified its revised Schedule M in December 2023. Larger manufacturers had to comply first. Meanwhile, the extended deadline for smaller units ran until 31 December 2025. As a result, every unit now needs GMP-ready processes. Exporters also follow standards such as WHO good manufacturing practices.
2. Paper records cannot keep up
Manual systems create serious risk. For example, batch deviations go unnoticed, documentation errors creep in, and traceability gaps delay approvals. In addition, compliance failures can lead to penalties. Paper simply cannot show an inspector the full history of a batch in minutes.
3. Data integrity matters more
Regulators now look closely at who changed a record, when and why. For instance, the US FDA’s 21 CFR Part 11 guidance covers electronic records and signatures. Therefore, a pharmaceutical business process needs audit trails, not loose spreadsheets.
4. Expiry losses and stock risk
Medicines and materials have a limited shelf life. So when stock rotation depends on memory, expired goods pile up. Also, mixing approved and quarantined stock can put a whole batch at risk.
5. Thin margins
Price pressure leaves little room for waste. However, many companies still estimate batch costs at month-end. As a result, they find losses too late to act.
Manual vs digital pharmaceutical business process
The table below compares a typical manual setup with the same work on eresource Bpro:
| Process | Manual or disconnected | On eresource Bpro ERP |
|---|---|---|
| Formulation | Recipes in files, so versions get mixed up | Version-controlled formulas with approval workflows |
| Batch records | Paper BMR and BPR | Electronic batch records, so every step is logged |
| Traceability | Slow searches across registers | Forward and backward batch genealogy |
| Quality control | Lab results kept in separate registers | Inward, in-process and finished goods QC, plus COA generation |
| Deviations | Tracked in emails and notebooks | Deviation and CAPA tracking in one place |
| Inventory | Expiry spotted late | FEFO allocation, expiry alerts and quarantine controls |
| Costing | Month-end estimates | Batch-wise cost, plus standard vs actual comparison |
7 pharmaceutical business processes to digitize first
You do not need to change everything at once. Instead, start with the processes that carry the most compliance and cost risk.
1. Formulation and recipe management
Bpro manages multi-level formulas and recipes. It also tracks every revision and supports potency-based adjustments. So each batch follows the approved formula, and changes go through an approval workflow.
2. Batch manufacturing and eBMR
Electronic batch manufacturing records replace paper documentation. In addition, Bpro tracks batch yield, variance and rework in real time. As a result, supervisors spot problems while the batch is still running.
3. Traceability and batch genealogy
Bpro tracks APIs, excipients, intermediates and finished goods by lot. Therefore, you can trace any batch forward to customers or backward to suppliers. It also supports batch split, merge and reclassification.
4. Quality control, QA and stability
Your QC team records lab tests, assay results, stability studies and validation data in the system. Then Bpro generates the COA and links it to the batch. Also, deviations and corrective actions (CAPA) stay visible until someone closes them. For more on this, read how to produce products as per cGMP requirements.
5. Warehouse, quarantine and expiry
Bpro keeps approved, rejected and quarantined stock apart. It also manages restricted zones, temperature control and material release. Meanwhile, FEFO allocation and expiry alerts help you use older stock first.
6. Planning, maintenance and packaging
MRP-driven planning matches production to demand and material availability. Bpro also schedules reactors and vessels, and it tracks preventive maintenance, calibration and equipment validation. Finally, packaging workflows print batch and expiry labels.
7. Purchase, sales and finance
Purchase teams compare quotations and qualify vendors before they buy. Then sales teams allocate specific batches to orders and attach the COA at dispatch. At the same time, production and inventory post to the books automatically, so finance sees the true cost of every batch.
How eresource Bpro supports pharma compliance
eresource designed Bpro for highly regulated pharmaceutical manufacturing, unlike generic ERP software. It supports FDA, WHO-GMP, EU-GMP, MHRA, Schedule M and 21 CFR Part 11 compliance. With Bpro, the system records every batch digitally and logs every validation step. It also links every material lot and tracks every deviation. So your compliance documents stay audit-ready, and inspection readiness improves.
Bpro supports a wide range of pharma businesses:
- API and bulk drug manufacturers
- Formulation units, including tablet and capsule makers
- Injectable, sterile, syrup and suspension units
- Contract manufacturing organizations (CMOs) and multi-plant companies
Bpro is part of the eresource process manufacturing ERP, so it also covers finance, purchase, sales and HR on the same platform. You can also explore the wider benefits of ERP in the pharma sector.
How to change your pharmaceutical business process, step by step
A planned rollout keeps production running while you change. Here is a simple path:
- Map today’s process: first, list where deviations, expiry losses and audit findings come from.
- Pick the critical areas: then start with batch records, QC and traceability.
- Choose a pharma-ready ERP: next, look for eBMR, batch genealogy and CAPA, rather than a generic system.
- Clean your master data: after that, fix item codes, formulas and vendor records before migration.
- Train and go live in phases: train each team, and then move one area at a time.
- Measure the results: finally, track deviations, expiry write-offs and batch cost variance every month.
eresource has completed 3,000+ implementations over 20+ years. Also, its no-code setup and functional champions help you go live faster. Read more about why eresource is an easy to implement ERP. Alternatively, see our guide to batch manufacturing software.
Ready to see your own process on Bpro? Book a free demo, or request a free ERP assessment first.
Frequently asked questions
What is a pharmaceutical business process?
A pharmaceutical business process is a set of steps a pharma company follows to buy materials and to make, test, store and sell medicines. Examples include formulation, batch manufacturing, quality control, batch release and dispatch.
Why must pharma companies change their business processes?
GMP rules are stricter, and buyers expect full traceability. Also, regulators check data integrity closely. Paper and spreadsheet processes struggle to meet these needs, so companies move to digital records and ERP.
What is revised Schedule M?
Revised Schedule M is India’s updated set of good manufacturing practice rules for drug makers. The government notified it in December 2023. Larger firms had to comply first, while the extended deadline for smaller units ran until 31 December 2025.
How does ERP help pharmaceutical compliance?
An ERP keeps electronic batch records, lot-wise traceability, QC results, COAs and CAPA in one system. For example, eresource Bpro supports FDA, WHO-GMP, EU-GMP, MHRA, Schedule M and 21 CFR Part 11 compliance.
Which pharma companies can use eresource Bpro?
Bpro suits API and bulk drug makers, formulation units, tablet and capsule makers, and injectable and syrup units. It also suits contract manufacturers and multi-plant companies.
How do we get started?
Book a free demo. First, a consultant maps your current process on Bpro. Then you get clear answers on timelines, pricing and support.
Also Read – Challenges Faced by Pharmaceutical Companies
